Overview

Webcast ImageWebcast
35th Annual Cowen and Company Health Care Conference (Live)
03/03/15 at 11:20 a.m. ET
35th Annual Cowen and Company Health Care Conference
Tuesday, March 3, 2015 11:20 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
27th Annual ROTH Conference (Live)
03/10/15 at 10:30 a.m. PT
27th Annual ROTH Conference
Tuesday, March 10, 2015 10:30 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
Stock Quote
BLUE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$96.22
Change (%) Stock is Down 0.08 (0.08%)
Volume510,271
Data as of 02/26/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
02/25/15bluebird bio Reports Fourth Quarter and Full Year 2014 Financial Results and Recent Operational ProgressPrinter Friendly Version
02/24/15bluebird bio Announces Participation in Upcoming Investor ConferencesPrinter Friendly Version
02/05/15bluebird bio to Present at the Leerink Global Healthcare ConferencePrinter Friendly Version
02/02/15FDA Grants Breakthrough Therapy Designation to LentiGlobin for Treatment of Beta-Thalassemia MajorPrinter Friendly Version
Upcoming EventsMore >>
DateTitle
03/03/15 11:20 a.m. ET
35th Annual Cowen and Company Health Care Conference
03/10/15 10:30 a.m. PT
27th Annual ROTH Conference

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.